NEXTCURE INC. news, videos and press releases - Page 3
For more news please use our advanced search feature.
NEXTCURE INC. - More news...
NEXTCURE INC. - More news...
- NextCure to Give Three Presentations at Society for Immunotherapy of Cancer Annual Meeting
- NextCure to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
- NextCure to Present at the 19th Annual Morgan Stanley Global Healthcare Conference
- NextCure Reports Second Quarter 2021 Financial Results
- NextCure Initiates Phase 1/2 Clinical Trial of NC762 for Solid Tumors
- NextCure and Collaborators Publish Preclinical Data on Novel Immunomedicine NC410
- NextCure to Present at the JMP Securities Life Sciences Conference
- NextCure to Present Trials in Progress Poster for NC410 at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting
- NextCure Reports First Quarter 2021 Financial Results
- NextCure to Present at the BofA Securities 2021 Virtual Health Care Conference
- NextCure to Present at the 7th Annual Truist Securities Life Sciences Summit
- NextCure Presents Preclinical Data for NC762 at American Association for Cancer Research (AACR) Annual Meeting 2021
- NextCure to Present at the 20th Annual Needham Virtual Healthcare Conference
- NextCure Provides Business Update and Reports Fourth Quarter and Full Year 2020 Financial Results
- REMINDER: NextCure to Host Virtual R&D Update Event on March 4, 2021
- NextCure to Host Virtual R&D Update Event on March 4, 2021
- Dr. Han Myint Appointed as NextCure’s Chief Medical Officer
- NextCure Provides Updates on NC318 Clinical Program
- NextCure to Present at Piper Sandler Virtual 32nd Annual Healthcare Conference
- NextCure Reports Third Quarter 2020 Financial Results
- NextCure Announces Appointment of John G. Houston, Ph.D., to its Board of Directors
- NextCure to Present at Morgan Stanley Virtual 18th Annual Global Healthcare Conference
- NextCure Reports Second Quarter 2020 Financial Results
- NextCure to Present at BTIG Virtual Biotechnology Conference
- NextCure Provides an Interim Update of the Phase 2 Portion of the NC318 Monotherapy Phase 1/2 Trial and Announces Departure of Chief Medical Officer
- NextCure Initiates Phase 1/2 Clinical Study of NC410, a Novel Immunomedicine, for Solid Tumors
- NextCure Presents Biomarker Data and Updated Clinical Results from Phase 1 Portion of its NC318 Clinical Trial at the 2020 Virtual American Society of Clinical Oncology Annual Meeting
- NextCure Reports First Quarter 2020 Financial Results
- NextCure to Present at BofA Securities Virtual Health Care Conference
- NextCure Provides Update on Clinical Trial Activities Due to Impact of COVID-19 Pandemic
